NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ODAIA

ODAIA

Private
TorontoHealthcare & Life Scienceshttps://www.odaia.ai/

Last Round

Series B

May 1, 2023

Total Funding Raised

$40.4M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ODAIA is a life sciences technology company that provides an AI-powered software-as-a-service platform designed to help pharmaceutical companies innovate their commercial engagement strategies using predictive analytics and customer science.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Business Intelligence, Sales Enablement, NLP & Conversational AI, CRM

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

commercial intelligencepharma sales enablementpredictive analyticsHCP targetingomnichannel marketingpharma techhealthcare professionalHCPsales intelligencebiopharma softwareAI sales assistantVeeva integrationcommercial operationspharma CRMsales opsconversational AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ODAIA Comps

Public and private peers based on sector, stage, and business model.

ODAIA comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ODAIA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 1, 2023
Series AFeb 10, 2022
SeedSep 23, 2019

Key People

Founding team and executive leadership

Philip Poulidis

CEO And Co-Founder

Founding Team

Rebecca Skvorc

Chief Financial Officer

Executive Team

Mark Zou

Chief Product Officer

Executive Team

ODAIA Investors

Notable investors and investment history

ODAIA investors
InvestorRounds
Graphite VenturesSeries A, Series B
Threshold VenturesSeries B
Flint CapitalSeries B, Series A
Panache VenturesSeries A, Seed
MaRS Discovery DistrictSeries A, Seed
University of Toronto Early Stage TechnologySeed
Inovia CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 10, 2026

    Customers sign long-term, fixed-fee, recurring contracts.

  • Nov 2, 2025

    Added Verona Pharma plc as a customer.

ODAIA Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ODAIA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ODAIA's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range108
Year Founded2018
Last FundingMay 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.